Semler Scientific’s $466 Million Bitcoin Holdings Under Investigation by Law Firm for Possible Securities Violations
The post Semler Scientific’s $466 Million Bitcoin Holdings Under Investigation by Law Firm for Possible Securities Violations appeared on BitcoinEthereumNews.com.
Semler Scientific, a Nasdaq-listed company, is making headlines for its significant Bitcoin investments amid an ongoing legal scrutiny. The healthcare technology firm recently reported holding over $466 million in Bitcoin, even as it faces potential legal claims from a law firm representing its shareholders. Bragar Eagel & Squire, P.C. is investigating whether Semler violated federal securities laws, emphasizing the seriousness of the allegations. Semler Scientific’s Bitcoin strategy faces legal challenges as the company navigates potential federal investigations while amassing significant crypto assets. Semler Scientific’s Bitcoin Holdings Expand Amid Legal Challenges Semler Scientific has emerged as a significant player in the cryptocurrency market, holding a staggering $466 million worth of Bitcoin. Despite the ongoing scrutiny from a U.S. law firm investigating the company for potential securities violations, Semler continues to expand its digital asset portfolio. Recent reports indicate that the company purchased another $50 million in Bitcoin, bringing its total holdings to approximately 4,264 BTC. Legal Scrutiny from Bragar Eagel & Squire, P.C. As the company develops its crypto treasury, Semler faces potential legal repercussions. The law firm Bragar Eagel & Squire has initiated an investigation into whether the healthcare technology firm violated federal securities laws, urging shareholders to collaborate with their legal team. This inquiry follows an ongoing investigation by the U.S. Department of Justice concerning Semler’s reimbursement claims related to its QuantaFlo device, which has lingered since 2017. Historical Context of Semler’s Investigations The DOJ’s initial investigation into Semler’s business practices began in 2017, focusing on reimbursement irregularities. Follow-up requests were made over several subsequent years, reflecting the federal agency’s persistent interest in the company’s operations. Recently, it seems that discussions between Semler and the DOJ aimed at settlement have stalled, leading to uncertainty about the forthcoming legal outcome. Market Response and Future Implications Despite the legal challenges, Semler…
